-
25-08-2017, 09:57 AM
#15731
ODT's take on the meeting.....Directors and CEO on notice......$1.5 mill cash burn per month.... clock ticking..... but DD confident costs will be 'contained' this year.
Interesting year ahead for PEB. (Disc; not holding, but watching and waiting.)
-
25-08-2017, 10:27 AM
#15732
Member
It was interesting that David D, when talking about the two VA Centers that are now sending in tests, mentioned that they did not need to do user programs for these two centers. Acceptance is slow but appears to be gaining traction.
-
25-08-2017, 10:37 AM
#15733
Originally Posted by Carpenterjoe
Thanks. PEB says these guys will need to pass all of the same hurdles and time delays that they have had to get this far. It might be easier for the second mover. The biggest competition appears to be urologists reluctance to change. Kaiser may well be the key (but I am sure they are aware of that and are playing hardball) The DHBs that have adopted PEB tests quickly reduced their wait lists. Any health bureaucrat worth their salt will realise that using these tests is good PR, saves money and improves patient outcomes.
-
25-08-2017, 10:42 AM
#15734
Did quite a few shareholders vote against David being reelected as a Director?
“ At the top of every bubble, everyone is convinced it's not yet a bubble.”
-
25-08-2017, 10:43 AM
#15735
Originally Posted by Arthur
AGM thoughts. Bureaucrats and process will decide if the company dies or thrives. The directors admit time is ticking, but say they have no control over the timing of any formative customers. Kaiser is meant to be itching to use the tests, put the paperwork seems never ending. There are so many other things happening at Kaiser that these tests are insignificant to them. When (if) the deal is signed they will be fast to implement (the planning is in place for acceptance). The American director said they were doing well in the CMS process. In his experience progress was faster than he would have expected. On the bright side 2 of the VA centres targeted have already taken the tests on board. They have expanded the target VA centre group to 14, up from an initial 5. Mid Central health is significant, there is high expectations others will be forced to follow their lead.
There was a clinical slide shown at the AGM that provided compelling evidence as the the need for PEB tests. Schedule price is over $2,000 a test (higher than I thought it would be). My gut feeling is that in 5 years this with either have gone under or will be worth $5 a share. I will hold
Thank you for your thoughts, it is much appreciated (I am a fellow holder).
I note there was no mentioned of an impending need for capital so things can't be that bad (can they?)
Originally Posted by winner69
Did quite a few shareholders vote against David being reelected as a Director?
Probably a protest vote - no surprises.
-
25-08-2017, 10:51 AM
#15736
Originally Posted by trader_jackson
Probably a protest vote - no surprises.
[/FONT]
But 12.66% vote NO for both Williams and our beloved David is some protest
I would hazard it a guess it is a group of some of the larger insto shareholders (seeing similar %ages for both)
More than a protest I reckon - dissatisfaction more like it
Don't directors normally get 99% plus in these things
PS - Balance doesn't have quite that many shares so not him
Last edited by winner69; 25-08-2017 at 10:58 AM.
“ At the top of every bubble, everyone is convinced it's not yet a bubble.”
-
25-08-2017, 11:04 AM
#15737
Originally Posted by winner69
But 12.66% vote NO for both Williams and our beloved David is some protest
I would hazard it a guess it is a group of some of the larger insto shareholders (seeing similar %ages for both)
More than a protest I reckon - dissatisfaction more like it
Don't directors normally get 99% plus in these things
PS - Balance doesn't have quite that many shares so not him
Could be one of the instos - they do own most of the company these days, they don't want to sell and book a loss (hardly any SSH notices this year), but still want to make a statement that they aren't a happy chappy
-
25-08-2017, 11:14 AM
#15738
Originally Posted by winner69
But 12.66% vote NO for both Williams and our beloved David is some protest
I would hazard it a guess it is a group of some of the larger insto shareholders (seeing similar %ages for both)
More than a protest I reckon - dissatisfaction more like it
Don't directors normally get 99% plus in these things
You might want to have a look at MPG... 28.4% - thats over 1 in 4 people (not just 1 angry insto) who voted no to Sir John Goulter being elected as a Director of Metro Performance Glass...
(and he's a Sir)
And unlike PEB, 61.2% of the issued capital voted (PEB not even half, 44.1%, voted)... that's what you call dissatisfaction I reckon.
Makes Williams and old DD look like a star in contrast don't you think?
Last edited by trader_jackson; 25-08-2017 at 11:17 AM.
-
25-08-2017, 11:26 AM
#15739
they acknowledge the long game......
but once again, on the cusp.
Medical Definition of cusp. 1: a point on the grinding surface of a tooth.
tbh being on this cusp sounds a bit painful
For clarity, nothing I say is advice....
-
25-08-2017, 11:42 AM
#15740
Originally Posted by barney
It was interesting that David D, when talking about the two VA Centers that are now sending in tests, mentioned that they did not need to do user programs for these two centers. Acceptance is slow but appears to be gaining traction.
There are 152 VA Medical Centers and 1400 out patient clinics. If they can gain traction here it will buy them a few more months (seems the biggest short term hope at this stage)
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks